The Journal of Infectious Diseases · 2017 · 119 citations · 24 references
Life SciencesNeurologyNeuroscienceHepatologyMolecular VirologyVirologyAntiviral TherapyEmbryonic Stem CellsInterferon-based TherapyLiver DiseaseViral HepatitisViral Hepatitis TreatmentChronic Viral HepatitisHepatic Viral InfectionsHepatitis E Virus InfectionNeurotropic Viral PathogenesisNeuroviral PathogenesisTreatment Of Hepatitis EViral Hepatitis Pathogenesis
Hepatitis E virus (HEV), as a hepatotropic virus, is supposed to exclusively infect the liver and only cause hepatitis. However, a broad range of extrahepatic manifestations (in particular, idiopathic neurological disorders) have been recently reported in association with its infection. In this study, we have demonstrated that various human neural cell lines (embryonic stem cell-derived neural lineage cells) induced pluripotent stem cell-derived human neurons and primary mouse neurons are highly susceptible to HEV infection. Treatment with interferon-α or ribavirin, the off-label antiviral drugs for chronic hepatitis E, exerted potent antiviral activities against HEV infection in neural cells. More importantly, in mice and monkey peripherally inoculated with HEV particles, viral RNA and protein were detected in brain tissues. Finally, patients with HEV-associated neurological disorders shed the virus into cerebrospinal fluid, indicating a direct infection of their nervous system. Thus, HEV is neurotropic in vitro, and in mice, monkeys, and possibly humans. These results challenge the dogma of HEV as a pure hepatotropic virus and suggest that HEV infection should be considered in the differential diagnosis of idiopathic neurological disorders.
24
Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant
Robert L. Martuza, Amy Malick, James M. Markert et al. · Science · 1991 · 1K citations
Medicine, Cancer Biology, Oncology +14
Priyanka Shukla, Hanh Nguyen, Kristina Faulk et al. · Journal of Virology · 2012 · 278 citations · Full text